NCT01093638View on ClinicalTrials.gov

Oral Formulation of Insulin for Preterm Infants

PHASE2TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2013

Study Completion Date

January 31, 2016

Conditions
Premature Birth of Newborn
Interventions
BIOLOGICAL

Oral Formulation of Insulin

Oral formulation of insulin fed concomitantly with infant formula

BIOLOGICAL

Placebo

Oral formulation of placebo fed concomitantly with infant formula

Trial Locations (1)

4244916

NICU, Laniado Hospital, Netanya

Sponsors

Lead Sponsor

Elgan Pharma Ltd.
All Listed Sponsors
lead

Elgan Pharma Ltd.

INDUSTRY